SCM
DMRA

Sterling Capital Management’s Damora Therapeutics, Inc. Ordinary Shares DMRA Stock Holding History

Sterling Capital Management’s Portfolio DMRA Stock Details DMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.1K Buy
+464
New +$11.2K ﹤0.01% 2120

Other funds holding DMRA

Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
State of New Jersey Common Pension Fund D
State of New Jersey Common Pension Fund D Trenton, New Jersey $29.3B AUM 38.15% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

Sterling Capital Management's DMRA Position: Q2 2026 in Review

Sterling Capital Management opened a new position in Damora Therapeutics, Inc. Ordinary Shares (DMRA) in Q2 2026: 464 shares worth $12.1K. The stake represents ﹤0.01% of the portfolio and ranks #2120 among its holdings.

7 funds tracked by Wall St. Rank hold DMRA as of Q2 2026.

  • Sterling Capital Management held 464 shares of Damora Therapeutics, Inc. Ordinary Shares worth $12.1K as of Q2 2026.
  • Damora Therapeutics, Inc. Ordinary Shares was a new Sterling Capital Management position in Q2 2026.
  • Damora Therapeutics, Inc. Ordinary Shares made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #2120 holding.
  • 7 funds tracked by Wall St. Rank held Damora Therapeutics, Inc. Ordinary Shares as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.